Purchases and Sales Made in Q3 2024 in Sana Biotechnology, Inc. (SANA)
This table provides information about the institutional ownership of Sana Biotechnology, Inc. (SANA) during Q3 2024. The information is specifically focused on institutions that hold shares of Sana Biotechnology, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-34.4K- 3.61% |
$129K - $236K
|
917K
$2.74M
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-34.4K- 3.61% |
$129K - $236K
|
917K
$2.74M
|
|
Nov 13, 2024
Q3 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-34.5K- 7.47% |
$130K - $237K
|
427K
$1.28M
|
|
Nov 14, 2024
Q3 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-46.6K- 51.55% |
$175K - $319K
|
43.8K
$131K
|
|
Feb 07, 2025
Q3 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-46.6K- 51.55% |
$175K - $319K
|
43.8K
$131K
|
|
Nov 14, 2024
Q3 2024
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-50.7K- 39.85% |
$191K - $348K
|
76.5K
$229K
|
|
Nov 14, 2024
Q3 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-64.9K- 14.67% |
$244K - $445K
|
378K
$1.13M
|
|
Nov 14, 2024
Q3 2024
|
Graham Capital Management, L.P.
Rowayton, CT |
SELL
|
- |
-75.3K- 77.72% |
$283K - $516K
|
21.6K
$64.5K
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-105K- 66.2% |
$393K - $718K
|
53.4K
$160K
|
|
Nov 13, 2024
Q3 2024
|
Crestline Management, LP
Fort Worth, TX |
SELL
|
- |
-140K- 4.34% |
$526K - $960K
|
3.09M
$9.23M
|
|
Nov 12, 2024
Q3 2024
|
Ci Private Wealth, LLC
Miami, FL |
SELL
|
- |
-155K- 25.54% |
$583K - $1.06M
|
452K
$1.35M
|
|
Nov 14, 2024
Q3 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-167K- 27.05% |
$627K - $1.14M
|
450K
$1.34M
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-208K- 68.67% |
$783K - $1.43M
|
95K
$284K
|
|
Nov 14, 2024
Q3 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-229K- 7.34% |
$861K - $1.57M
|
2.89M
$8.64M
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
SELL
|
- |
-250K- 70.41% |
$941K - $1.72M
|
105K
$314K
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-267K- 64.63% |
$1M - $1.83M
|
146K
$437K
|
|
Nov 05, 2024
Q3 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-293K- 2.77% |
$1.1M - $2.01M
|
10.3M
$30.7M
|
|
Nov 14, 2024
Q3 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-1.18M- 75.99% |
$4.45M - $8.12M
|
374K
$1.12M
|